Your browser doesn't support javascript.
loading
Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patients.
Baccelli, Irène; Stenzinger, Albrecht; Vogel, Vanessa; Pfitzner, Berit Maria; Klein, Corinna; Wallwiener, Markus; Scharpff, Martina; Saini, Massimo; Holland-Letz, Tim; Sinn, Hans-Peter; Schneeweiss, Andreas; Denkert, Carsten; Weichert, Wilko; Trumpp, Andreas.
Afiliación
  • Baccelli I; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. Divison of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
  • Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany.
  • Vogel V; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. Divison of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. Institute of Pathology, Universi
  • Pfitzner BM; Institute of Pathology, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
  • Klein C; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. Divison of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
  • Wallwiener M; National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.
  • Scharpff M; National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.
  • Saini M; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. Divison of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
  • Holland-Letz T; Department of Biostatistics, Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld TP4, 69120 Heidelberg, Germany.
  • Sinn HP; Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany.
  • Schneeweiss A; National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.
  • Denkert C; Institute of Pathology, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.
  • Weichert W; Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany. National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany. German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.
  • Trumpp A; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. Divison of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. German Cancer Consortium (DKTK),
Oncotarget ; 5(18): 8147-60, 2014 Sep 30.
Article en En | MEDLINE | ID: mdl-25230070
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma / Biomarcadores de Tumor / Proteínas Proto-Oncogénicas c-met / Antígeno CD47 / Células Neoplásicas Circulantes Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies Idioma: En Revista: Oncotarget Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma / Biomarcadores de Tumor / Proteínas Proto-Oncogénicas c-met / Antígeno CD47 / Células Neoplásicas Circulantes Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies Idioma: En Revista: Oncotarget Año: 2014 Tipo del documento: Article